APA (7th ed.) Citation

Mao, Y., Wang, S., Gao, T., Zhang, N., Liang, X., Xie, F., . . . Ma, J. (2023). Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: Open label, non-inferiority, multicentre, randomised, phase 3 trial. BMJ (Online), 380, e072133. https://doi.org/10.1136/bmj-2022-072133

Chicago Style (17th ed.) Citation

Mao, Yan-Ping, et al. "Medial Retropharyngeal Nodal Region Sparing Radiotherapy Versus Standard Radiotherapy in Patients with Nasopharyngeal Carcinoma: Open Label, Non-inferiority, Multicentre, Randomised, Phase 3 Trial." BMJ (Online) 380 (2023): e072133. https://doi.org/10.1136/bmj-2022-072133.

MLA (9th ed.) Citation

Mao, Yan-Ping, et al. "Medial Retropharyngeal Nodal Region Sparing Radiotherapy Versus Standard Radiotherapy in Patients with Nasopharyngeal Carcinoma: Open Label, Non-inferiority, Multicentre, Randomised, Phase 3 Trial." BMJ (Online), vol. 380, 2023, p. e072133, https://doi.org/10.1136/bmj-2022-072133.